Ghrelin inhibits angii-induced expression of TNF-α, IL-8, MCP-1 in human umbilical vein endothelial cells

International Journal of Clinical and Experimental Medicine

Volumn 8, Issue 1, 2015, Pages 579-588

  Zhang, Bin ^b   Fang, Fang ^a   Yang, Tianlu ^a   Yu, Zaixin ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Atherosclerosis; Ghrelin; Inflammation; Interleukin 8; Monocyte chemoattractant protein 1; NF B and MAPK pathways; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN II; GHRELIN; GHRELIN RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

EID: 84922987721     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402: 656-60.
2. Tang NP, Wang LS, Yang L, Gu HJ, Zhu HJ, Zhou B, Sun QM, Cong RH, Wang B. Preproghrelin Leu72Met polymorphism in Chinese subjects with coronary artery disease and controls. Clin Chim Acta 2008; 387: 42-7.
3. Katugampola SD, Pallikaros Z, Davenport AP. [125I-His (9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis. Br J Pharmacol 2001; 134: 143-9.
4. Zhang M, Fang WY, Yuan F, Qu XK, Liu H, Xu YJ, Chen H, Yu YF, Shen Y, Zheng ZC. Plasma ghrelin levels are closely associated with severity and morphology of angiographically-detected coronary atherosclerosis in Chinese patients with diabetes mellitus. Acta Pharmacol Sin 2012; 33: 452-8.
5. Chang L, Ren Y, Liu X, Li WG, Yang J, Geng B, Weintraub NL, Tang C. Protective effects of ghrelin on ischemia/reperfusion injury in the isolated rat heart. J Cardiovasc Pharmacol 2004; 43: 165-70.
6. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, Kangawa K, Kohno N, Yoshizumi M. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830-5.
7. Caliskan Y, Gorgulu N, Yelken B, Yazici H, Oflaz H, Elitok A, Turkmen A, Bozfakioglu S, Sever MS. Plasma ghrelin levels are associated with coronary microvascular and endothelial dysfunction in peritoneal dialysis patients. Ren Fail 2009; 31: 807-13.
8. Demers A, Caron V, Rodrigue-Way A, Wahli W, Ong H, Tremblay A. A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages. PLoS One 2009; 4: e7728.
9. Zhang M, Yuan F, Liu H, Chen H, Qiu X, Fang W. Inhibition of proliferation and apoptosis of vascular smooth muscle cells by ghrelin. Acta Biochim Biophys Sin 2008; 40:769-76.
10. Baldanzi G, Filigheddu N, Cutrupi S, Catapano F, Bonissoni S, Fubini A, Malan D, Baj G, Gra-nata R, Broglio F, Papotti M, Surico N, Bussolino F, Isgaard J, Deghenghi R, Sinigaglia F, Prat M, Muccioli G, Ghigo E, Graziani A. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 2002; 159: 1029-37.
11. Zhang M, Yuan F, Chen H, Qiu X, Fang W. Effect of exogenous ghrelin on cell differentiation antigen 40 expression in endothelial cells. Acta Biochim Biophys Sin 2007; 39: 974-81.
12. Skilton MR, Nakhla S, Sieveking DP, Caterson ID, Celermajer DS. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells. Clin Exp Pharmacol Physiol 2005; 32: 839-44.
13. Li WG, Gavrila D, Liu X, Wang L, Gunnlaugsson S, Stoll LL, McCormick ML, Sigmund CD, Tang C, Weintraub NL. Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells. Circulation 2004; 109: 2221-6.
14. Vörös K, Prohászka Z, Kaszás E, Alliquander A, Terebesy A, Horváth F, Janik L, Sima A, Forrai J, Cseh K, Kalabay L. Serum ghrelin level and TNF-α/ghrelin ratio in patients with previous myocardial infarction. Arch Med Res 2012; 43: 548-54.
15. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 2008; 31: 515-23.
16. Li CH, Zhang XC. The effect of activation peroxidase proliferation activated receptor on AngⅡinduced expression of monocyte chemoattractant protein-1 in Human Umbilical Vein Endothelial Cells. Chinese Journal of Geriatrics 2006; 25: 664-7.
17. Jiang XY, Gao GD, Zhou J, Guo R, Li YX. Role of AT2 receptors on angiotensin II-induced tumor necrosis factor alpha and interleukin 1 beta secretion in adult rat cardiac fibroblasts. Nan Fang Yi Ke Da Xue Xue Bao 2007; 27: 1307-9.
18. Puissant C, Houdebine LM. An improvement of the single-step method of RNA isolation by ac-id guanidinium thiocyanate-phenol-chloroform extraction. Biotechniques 1990; 8: 148-9.
19. Krzesz R, Wagner AH, Cattaruzza M, Hecker M. Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor kappa B and signal transducer and activation of transcription-1. FEBS Lett 1999; 453: 191-6.
20. Tian F, Zang WD, Hou WH, Liu HT, Xue LX. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA. Acta Biochim Biophys Sin 2006; 38: 318-26.
21. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deqhenqhi R, Ghigo E. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001; 86: 5083-86.
22. Li Y, Hai J, Li L, Chen X, Peng H, Cao M, Zhang Q. Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 2013; 43: 376-86.
23. Kasımay O, Işeri SO, Barlas A, Bangir D, Yeğen C, Arbak S, Yeğen BC. Ghrelin ameliorates pancreaticobiliary inflammation and associated remote organ injury in rats. Hepatol Res 2006; 36: 11-9.
24. Sibilia V, Rindi G, Pagani F, Rapetti D, Locatelli V, Torsello A, Campanini N, Deghenghi R, Netti C. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 2003; 144: 353-9.
25. Nagaya N, Kanqawa K. Ghrelin improves left ventricular dysfunction and cardiac cachexia in heart failure. Curr Opin Pharmacol 2003; 3: 146-51.
26. Schillaci G, Pirro M, Gemelli F, Pasqualini L, Vaudo G, Marchesi S, Siepi D, Bagaglia F, Man-narino E. Increased C-reactive protein concentrations in never-treated hypertension: the role of systolic and pulse pressure. J Hypertens 2003; 21: 1841-6.
27. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens 2002; 20: 593-6.
28. Gerszten RE. Pleiotropic effects of chemokines in vascular lesion development. Artherioscler Thromb Vasc Biol 2002; 22: 528-9.
29. Libby P, Mra AM. Inflammation and atherosclerosis. Circulation 105: 1135-43.
30. Manfredi Tesauro FS, Micaela Iantorno SR, Domenico Melina DL, Cardillo C. Ghrelin Im-proves Endothelial Function in Patients With Metabolic Syndrome. Circulation 2005; 112: 2986-92.
31. Shimizu Y, Nagaya N, Teranishi Y, Imazu M, Yamamoto H, Shokawa T, Kangawa K, Kohno N, Yoshizumi M. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats. Biochem Biophys Res Commun 2003; 310: 830-5.
32. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br J Pharmacol 2002; 136: 1146-52.
33. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R, Lillard JW Jr, Taub DD. Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66.
34. Gonzalez-Rey E, Chorny A, Delgado M. Thera-peutic action of ghrelin in a mouse model of colitis. Gastroenterology 2006; 130: 1707-20.
35. Dembinski A, Warzecha Z, Ceranowicz P, To-maszewska R, Stachura J, Konturek SJ, Kon-turek PC. Ghrelin attenuates the development of acute pancreatitis in rat. J Physiol Pharmacol 2003; 54: 561-73.
36. Kim YI, Kang YJ, Song IH, Choi HC, Kim HS. Upregulation of Interleukin-8/CXCL8 in Va-scular Smooth Muscle Cells from Sponta-neously Hypertensive Rats. Hypertens Res 2008; 31: 515-23.
37. Mazzocchi G, Neri G, Rucinski M, Rebuffat P, Spinazzi R, Malendowicz LK, Nussdorfer GG. Ghrelin enhances the growth of cultured human adrenal zona glomerulosa cells by exerting MAPK-mediated proliferogenic and antiapoptotic effects. Peptides 2004; 25: 1269-77.
38. Kim MS, Yoon CY, Jang PG, Park YJ, Shin CS, Park HS, Ryu JW, Pak YK, Park JY, Lee KU, Kim SY, Lee HK, Kim YB, Park KS. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol 2004; 18: 2291-301.
39. Murata M, Okimura Y, Iida K, Matsumoto M, Sowa H, Kaji H, Kojima M, Kanqawa K, Chihara K. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem 2002; 277: 5667-74.